Literature DB >> 34825820

Macrophage-Mediated Porous Magnetic Nanoparticles for Multimodal Imaging and Postoperative Photothermal Therapy of Gliomas.

Sheng Wang1,2, Hailin Shen3, Qiulian Mao4, Qing Tao1,2, Guotao Yuan4, Lingli Zeng4, Ziying Chen5, Yunjiao Zhang5, Liang Cheng6, Jingzhong Zhang7, Hui Dai1,2, Chunhong Hu1,2, Yue Pan4, Yonggang Li1,2.   

Abstract

Because of the blood-brain barrier and the high infiltration of glioma cells, the diagnostic accuracy and treatment efficiency of gliomas are still facing challenges. There is an urgent need to explore the integration of diagnostic and therapeutic methods to achieve an accurate diagnosis, guide surgery, and inhibit postoperative recurrence. In this work, we developed a macrophage loaded with a photothermal nanoprobe (MFe3O4-Cy5.5), which is able to cross the blood-brain barrier and accumulate into deep gliomas to achieve multimodal imaging and guided glioma surgery purposes. With desirable probing depth and high signal-to-noise ratio, Fe3O4-Cy5.5 can perform fluorescence, photoacoustic, and magnetic resonance imaging, which can distinguish brain tumors from the surrounding normal tissues and accurately guide glioma resection. Meanwhile, Fe3O4-Cy5.5 can effectively induce local photothermal therapy and inhibit the recurrence of glioma after surgery. These results demonstrate that the macrophage-mediated Fe3O4-Cy5.5, which can achieve a multimodal diagnosis, accurate imaging-guided surgery, and effective photothermal therapy, is a promising nanoplatform for gliomas.

Entities:  

Keywords:  glioma; macrophages; magnetic resonance imaging; photothermal therapy; porous magnetic nanoparticles

Mesh:

Substances:

Year:  2021        PMID: 34825820     DOI: 10.1021/acsami.1c12406

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  1 in total

Review 1.  Iron-Based Hollow Nanoplatforms for Cancer Imaging and Theranostics.

Authors:  Shun Luo; Shuijie Qin; Gerile Oudeng; Li Zhang
Journal:  Nanomaterials (Basel)       Date:  2022-08-31       Impact factor: 5.719

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.